Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/18/9/1477/538626/mdm209.pdf
Reference29 articles.
1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group (EBCTCG);Lancet,2005
2. Chemotherapy: what progress in the last 5 years?;Hamilton;J Clin Oncol,2005
3. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer;Goldhirsch;J Clin Oncol,2003
4. The contribution of molecular markers to the prediction of response in the treatment of breast cancer: a review of the literature on HER-2, p53 and BCL-2;Hamilton;Ann Oncol,2000
5. Breast cancer classification and prognosis based on gene expression profiles from a population-based study;Sotiriou;Proc Natl Acad Sci U S A,2003
Cited by 73 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prognostic value of basal markers (epidermal growth factor receptor “EGFR” and cytokeratin 5/6) expression in triple-negative invasive breast cancer;Journal of the Pakistan Medical Association;2023-05-25
2. Benzimidazole carbamate induces cytotoxicity in breast cancer cells via two distinct cell death mechanisms;Cell Death Discovery;2023-05-13
3. Resveratrol Analogs and Prodrugs Differently Affect the Survival of Breast Cancer Cells Impairing Estrogen/Estrogen Receptor α/Neuroglobin Pathway;International Journal of Molecular Sciences;2023-01-21
4. Predictive and prognostic relevance of immunohistochemical testing of estrogen and progesterone receptors in breast cancer in South East Nigeria: A review of 417 cases;Rare Tumors;2021-01
5. Functional Metabolomics and Chemoproteomics Approaches Reveal Novel Metabolic Targets for Anticancer Therapy;Advances in Experimental Medicine and Biology;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3